# Efficacy of LiveSpo COLON as a Supportive Treatment for Inflammatory Bowel Disease (IBD)

> **NCT06637683** · NA · COMPLETED · sponsor: **Anabio R&D** · enrollment: 60 (actual)

## Conditions studied

- Inflammatory Bowel Diseases

## Interventions

- **COMBINATION_PRODUCT:** LiveSpo COLON
- **OTHER:** Routine treatment

## Key facts

- **NCT ID:** NCT06637683
- **Lead sponsor:** Anabio R&D
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-15
- **Primary completion:** 2020-03-15
- **Final completion:** 2020-06-20
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2024-10-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06637683

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06637683, "Efficacy of LiveSpo COLON as a Supportive Treatment for Inflammatory Bowel Disease (IBD)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06637683. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*